SOUTH SAN FRANCISCO, Calif., July 17, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that Robert Walsh, Senior Vice President and Head of Intrexon's Energy Sector, will present at the following industrial biotechnology conferences:


    --  BIO World Congress on Industrial Biotechnology in The Importance of
        Feedstock and Product Strategy session, July 22, 2015, at 10:30 a.m.
        Eastern Time at the Palais des congres de Montreal in Montreal, Canada;

    --  GTL Technology Forum 2015 in The Future of Non FT GTL session, July 29,
        2015, at 11:25 a.m. Central Time at the Norris Conference Center - City
        Center in Houston; and

    --  Jefferies 2015 Industrials Conference, August 10, 2015, at 2:00 p.m.
        Eastern Time at the Grand Hyatt in New York City.

http://photos.prnewswire.com/prnvar/20130919/NY83283LOGO

Mr. Walsh's presentations will highlight the advantages of Intrexon's methanotroph bioconversion platform to convert natural gas into high-value fuels and chemicals.

About Intrexon Corporation

Intrexon Corporation (NYSE:XON) is Powering the Bioindustrial Revolution with Better DNA(TM) to create biologically-based products that improve the quality of life and the health of the planet. The Company's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA(®), and we invite you to discover more at www.dna.com.

Safe Harbor Statement

Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.

For more information regarding Intrexon Corporation, contact:
Investor Contact:

Christopher Basta
Vice President, Investor Relations
Tel: +1 (561) 410-7052
investors@intrexon.com

Corporate Contact:
Marie Rossi, Ph.D.
Senior Manager, Technical Communications
Tel: +1 (301) 556-9850
publicrelations@intrexon.com

Logo - http://photos.prnewswire.com/prnh/20130919/NY83283LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/intrexon-to-present-at-upcoming-industrial-biotechnology-conferences-300114775.html

SOURCE Intrexon Corporation